| Product NDC: | 0409-3218 |
| Proprietary Name: | A-METHAPRED |
| Non Proprietary Name: | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Active Ingredient(s): | 125 mg/2mL & nbsp; METHYLPREDNISOLONE SODIUM SUCCINATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-3218 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040665 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120221 |
| Package NDC: | 0409-3218-05 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3218-05) > 2 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0409-3218-05 |
| Proprietary Name | A-METHAPRED |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3218-05) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-3218 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20120221 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Strength Number | 125 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |